 |
|
|
|
|
|
|
| Article 1 to 7 out of 7 concerning Illumina, Inc.
|
-
Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project
(06/13/2008)
Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for ...
-
Illumina Sequences the First African Human Genome
(02/11/2008)
Accomplishment Marks a Significant Milestone Enabling Economical Human Genome Resequencing
Illumina, Inc. announced that scientists at the Company have sequenced the genome of an anonymous African male (Yoruba from Ibadan, Nigeria), using the Genome Analyzer. Sequencing of this HapMap sample was conducted internally and marks the first ...
-
Illumina Announces Corporate Reorganization
(01/08/2008)
Illumina, Inc. announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping businesses. Under the new structure, a newly created Life Sciences Business Unit will include all ...
-
Genizon Becomes Certified Service Provider Under Illumina's New CSPro Program
(08/11/2006)
Genizon BioSciences has become the first commercial organization to achieve certification under the new Certified Service Provider (CSPro) Program from Illumina, Inc. This certification assures compliance with the highest quality standards for ...
-
Illumina and ReaMetrix to Collaborate on Molecular Diagnostics and Market Development
(07/24/2006)
Illumina, Inc. and ReaMetrix, Inc. announced the formation of a diagnostic collaboration under which the companies plan to co-develop molecular diagnostic panels for a range of disease areas. Under the terms of the agreement, ReaMetrix will gain ...
-
deCODE and Illumina Form Alliance to Develop and Commercialize DNA-based Diagnostics
(05/17/2006)
Companies to initiate work on molecular diagnostics for the risk of heart attack, type 2 diabetes and breast cancer
deCODE genetics and Illumina, Inc. announced the formation of a strategic alliance under which the companies plan to co-develop and commercialize DNA-based diagnostic tests in several major disease areas. The alliance will employ Illumina's platform ...
-
PharmacoDesign Purchases Illumina Genotyping Solutions for Pharmacogenomics Research
(10/27/2005)
Illumina to Gain Exclusive, Licensed Access to Biomarkers Discovered Through Disease Studies
Illumina, Inc. announced an agreement of sale with PharmacoDesign (PD) for a BeadStation system and whole-genome genotyping arrays and reagents for ongoing pharmacogenomics studies. PharmacoDesign will genotype various Korean populations with the ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon